Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

A Member of the Law Professor Blogs Network

Friday, July 10, 2009

Lawyers, Drugs and Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry

Posted by D. Daniel Sokol

On Friday, September 25, 2009, at the University of San Francisco School of Law, AAI will co-host a symposium titled "Lawyers, Drugs and Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry." Panels.  This symposium will include five panels addressing cutting edge issues relevant to enforcement of antitrust laws in the pharmaceutical industry: 

  • Reverse Payments:  the legality of reverse payments in settling drug patent disputes;
  • Product Hopping:  the legality of brand name drug manufacturers engaging in product hopping to avoid generic competition;
  • Burdens of Proof:  burdens of proof for claims based on allegations of sham patent litigation, Walker Process violations and inequitable conduct before the patent office;
  • Standing and Preemption:  standing for monopolization claims for Walker Process violations and possible preemption by federal patent law; and
  • Class Certification:  the effect of current case law expanding the required showing for class certification in antitrust cases.

Participants.  The keynote speaker will be Prof. C. Scott Hemphill of Columbia Law School.  Panelists will include Meredyth Andrus, Assistant Attorney General, Maryland; Elizabeth Arthur, Assistant Attorney General, Florida;David Balto, Law Offices of David Balto; Lou Bograd, Center for Constitutional Litigation; Prof. Michael Carrier, Rutgers School of Law, Camden; Eric Cramer, Berger & Montague, P.C.; B.D. Daniel, Beck Redden & Secrest; Prof. Joshua Davis, University of San Francisco School of Law; Prof. Robin Feldman, University of California, Hastings; Jay Himes, Labaton Sucharow, LLP; Cheryl Johnson, Deputy Attorney General, California; Prof. Keith Leffler, University of Washington; Linda Nussbaum, Kaplan Fox; Doug Richards, Cohen Milstein; Steven Shadowen, Hangley Aronchick Segal & Pudlin; and David Sorensen, Berger & Montague, P.C.

Sponsors.  Co-Sponsors include USF School of Law, the American Antitrust Institute, the Rutgers Law Journal, Berger & Montague, P.C., Hangley Aronchik Segal & Pudlin, P.C., Kaplan Fox & Kilsheimer LLP, and Lieff, Cabraser Heimann & Bernstein, LLP.

MCLE credit will be provided.  Registration information is forthcoming.  For additional information please email lawfsoevents@usfca.edu.

http://lawprofessors.typepad.com/antitrustprof_blog/2009/07/lawyers-drugs-and-money-a-prescription-for-antitrust-enforcement-in-the-pharmaceutical-industry.html

| Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef011570a38185970c

Listed below are links to weblogs that reference Lawyers, Drugs and Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry:

Comments

Post a comment